# A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer

> **NCT00401570** · PHASE2 · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 40 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Volociximab
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00401570
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401570, "A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00401570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*